Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Centre Hospitalier Universitaire Dijon
The Institute of Molecular and Translational Medicine, Czech Republic
Ohio State University Comprehensive Cancer Center
Mayo Clinic
University Hospital, Toulouse
University of California, San Francisco
University Hospital, Caen
University of California, San Francisco